Ximing Xu

14PUBLICATIONS
46CO-AUTHORS
Cancer cell biologyPhysiotherapyAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 27, 2026
The evolving role of TP53 mutation in hepatocellular carcinoma (HCC).

|Sep 08, 2026
Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial.

|Mar 31, 2026
Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.

Xiaohong Liu, Daoming Zhang, Le Xu

|Dec 31, 2025
CYP8B1 inhibits hepatocellular carcinoma progression by repressing PAK4 transcription through inhibition of nuclear translocation of u-STAT1.

Le Xu, Lin Xiong, Jingping Yuan

|Oct 13, 2025
Risk factors and mechanisms of immune checkpoint inhibitor-related pneumonitis.

Yukai Chen, Le Xu, Shishi Zou

|Jun 12, 2025
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers.

Le Xu, Yukai Chen, Lin Xiong

Pageof 3

Frequent Collaborators

2 joint publications

Hua Zhu

2 joint publications

Xinyao Hu

2 joint publications

Lin Xiong

2 joint publications

Dedong Cao